Who
Timothy P. Walbert
Director
Company insider
Files Form 4 as: Director, Kardigan; Director, Mirum Pharmaceuticals; Director, BioMarin Pharmaceutical; Director, Odyssey Therapeutics; Director, Century Therapeutics; Director, Sagimet Biosciences; Chairman, President and CEO, Horizon Therapeutics Public Ltd Co; Director, Aurinia Pharmaceuticals.
In numbers
- Trades disclosed
- 479
- Buys
- 1
- Sells
- 46
- Bought
- $4,860
- Sold
- $139.4M
- Companies
- 16
- Companies where not an officer
- 13
- First trade
- 17 Jan 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | KARD Kardiganoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,573 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | KARD Kardiganoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,573 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,772 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,980 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —7,490 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BMRN BioMarin PharmaceuticalBiotechnology | SEC FORM 4 Code A | —7,490 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,977 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,977 | filing |
| 7 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,393 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,393 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | IPSC Century Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 9 Jun 2025filed 10 Jun 2025 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,250 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,703 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,268 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.